Angela Mastaloudis,Steve Wood,Jamie Louis Barger,Richard Weindruch,Tomas Alberto Prolla,Mark Bartlett,Scott B. Ferguson
申请号：
US15675761
公开号：
US20180078601A1
申请日:
2017.08.13
申请国别(地区):
US
年份:
2018
代理人:
摘要：
An oral formulation includes a plurality of agents that promote cellular detoxification. Agents can be included that modulate expression of Nrf2-associated genes upon ingestion of the oral formulation by a subject, wherein the Nrf2-associated genes include at least one gene encoding intrinsic antioxidants, and at least one gene encoding cellular detoxifiers. In addition, at least one of the plurality of agents attenuates inflammation.
